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Background: Our aim in the present study was to evaluate surgical outcomes and complications of pelvic
exenteration in the treatment of gynecologic malignancy and to compare surgery-related complications associated
with different types of exenteration.
Methods: We performed a retrospective analysis of patients who underwent pelvic exenteration for the treatment
of gynecologic cancer between January 2008 and August 2011. Patients were divided into two groups for comparison:
total pelvic exenteration (TPE) and nontotal pelvic exenteration (NTE, including anterior pelvic exenteration (APE)
posterior pelvic exenteration (PPE)). Outcomes are reported according to the modified Clavien-Dindo Classification of
Surgical Complications.
Results: Twenty-eight patients were included in the analysis. Eighteen had cervical cancer (64.3%). The prevalence of
stage IIIB cervical cancer was 55%. Primary treatment with radiotherapy was performed in 53.3% of patients. Fifty
percent of patients underwent TPE, 25% had APE and 25% underwent PPE. Patients who underwent TPE had worse
outcomes, with a mean operative time of 367 minutes, use of blood transfusion in 93% of patients, ICU stay of 4.3 days
and total hospital stay of 9.4 days. The overall mortality rate was 14.3%, and the surgical site infection rate was 25%. In
the TPE group, 78.6% of patients experienced surgical complications. One-fourth of the total patient sample required
reoperation, and the leading cause was urinary fistula (57.1%). Urinary leakage occurred in 22.7% of urinary reconstruction
patients. Wet colostomy was the most common form of reconstruction with 10% of leakage.
Conclusions: Postoperative urinary and infectious complications accounted for 75% of all causes of morbidity and
mortality after pelvic exenteration. TPE is a more complex and morbid procedure than NTE.
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In 1948, Brunschwig first described the pelvic exenter-
ation (PE) procedure with purely palliative intent [1].
Over the next decades, in several reports of the use of
this procedure as a curative treatment for pelvic or even
perineal tumors, attempts were made to establish a more
precise role for this operation [2-4].
The main indication for PE remains the treatment of
recurrent or persistent cervical cancer previously treated
with exclusive or concomitant chemoradiation [5]. PE in* Correspondence: petruzziello123@hotmail.com
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article, unless otherwise stated.gynecologic cancer has also been well-described, al-
though with less global experience, in the treatment of
primary ovarian cancer [6] and recurrent endometrial
cancer [7].
Those reports consistently describe high rates of
surgery-related complications. High morbidity remains
the most important barrier to the widespread use of this
operation [8-13]. Additionally, few research groups were
able to identify a specific risk category in which complica-
tions were more frequent. Furthermore, none of them
suggested corrective strategies that could be implemented.
The main purpose of our present study was to investi-
gate postoperative outcomes after PE for gynecologic
cancer. We also tried to identify a subgroup of patients
with a major risk for complications. We used the modifiedtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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(Clavien-Dindo Classification) [14] for the first time in a
PE series report, separately analyzing each type of PE: an-
terior (APE), posterior (PPE) and total (TPE).
Methods
After obtaining the approval of the local research ethics
committee of our institution, we reviewed and evaluated
all medical records of patients who underwent PE for
gynecologic cancer between January 2008 and August
2011 at our department. At the beginning of the proce-
dures, the surgeons sought to identify intrapelvic unresect-
able disease and/or extrapelvic metastasis. Any tissues that
raised suspicion of unresectability or metastasis were
biopsied and sent for frozen sectioning to confirm
unresectability.
For each patient, the following clinical variables were
reviewed: age, tumor site and histology, clinical stage
and previous therapy. For the analysis of intra- and post-
operative outcomes, procedures were divided into APE
(uterus plus bladder), PPE (uterus plus rectum) and TPE
(uterus plus bladder and rectum). APE and PPE were
analyzed separately and also grouped together as a “non-
total” pelvic exenteration group (NTE) and compared
with TPE.
In each group, the following surgical variables are de-
scribed: operative time (including both resection and re-
construction phases), amount of blood transfusion, time
spent in the ICU and length of hospital stay, intraopera-
tive complications, early postoperative complications (at
30 days), surgical site infection rate, need for reoperation
and operative mortality. Complications were graded ac-
cording to the Clavien-Dindo Classification [14]. Urinary
reconstructions are described separately, including related
complications and management strategies. StatisticalTable 1 Demographicsa
Overall APE
Number of patients 28 7 (25%










Previous radiotherapyb, n (%) 17 (61%) 7 (100%
aAPE, Anterior pelvic exenteration; PPE, Posterior pelvic exenteration; TPE = Total pe
combined.analysis was carried out using SPSS v.13 software (SPSS,
Chicago, IL, USA) and EPI Info 3.5 software (Centers for
Disease Control and Prevention, Atlanta, GA, USA), ap-




We reviewed the cases of a total of 28 women who
underwent PE between January 2008 and August 2011.
Their mean age was 54.7 years (range, 34 to 78 years).
The majority of patients presented with cervical cancer
(64.3%). Ovarian and uterine cancer, as well as one pa-
tient with vaginal cancer, represented the remaining
cases. In terms of cervical cancer, squamous cell carcin-
oma represented 83.3% of the sample. Among that sub-
group, clinical stage IIIB (according to American Joint
Committee on Cancer criteria) was the most common
(44.4%), followed by stage IIB (22.2%).
Additional demographic characteristics are shown in
Table 1, divided into surgical groups (APE, PPE and
TPE). These groups were similar in their characteristics,
except for the APE group, which showed significantly
higher prevalence of previous radiotherapy (RT). How-
ever, this distinction was no longer present when we
considered APE and PPE together as NTE.
Previous treatment
Preoperative treatment varied depending on the site of
the disease. We observed that the majority of patients
had previously been treated with a nonoperative ap-
proach. RT, either in combination with chemotherapy
(CT) or alone, was the standard treatment in the major-
ity of patients (53.6%), particularly in those with cervical
cancer (83.3%). All the remaining patients had hadPPE TPE P-value
) 7 (25%) 14 (50%) –








) 2 (28%) 8 (57%) (0.021)
lvic exenteration. bP = 0.698 for comparison of TPE with APE and PPE groups
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that 32.1% of the sample was composed of patients with
uterine or ovarian cancer, in which a primary surgical
approach is usually the standard of care.
Indication for the operation
In only three cases (one leiomyosarcoma of the uterine
cervix and two ovarian cystadenocarcinomas) was a pri-
mary surgical approach with PPE performed. In all the
remaining patients, the procedure was indicated for the
treatment of recurrent or persistent disease.
Type of procedure
According to type of exenteration, TPE accounted for
the majority of cases (50%), followed by APE (25%) and
PPE (25%).
Surgical outcomes
Detailed data on each type of PE are shown in Table 2.
Mean operative time for TPE was 367 minutes (range,
240 to 540 minutes), which is longer than for NTE
(271 minutes) (P = 0.02).
Other surgical outcomes showed worse results for
TPE, such as need for blood transfusion (93%), mean
units of packed red cell blood cells transfused (2.6),
length of ICU stay (4.3 days, ranging from 2 to 21) and
hospital stay (11.1 days, ranging from 5 to 24). However,
these results were not statistically significant.
Morbidity and mortality
There were major intraoperative complications in only
four patients: one case of accidental bladder injury, one
case of hemorrhagic shock due to vascular injury to iliac
vessels and two cases of uncontrolled fecal spillage into
the abdominal cavity. No intraoperative deaths occurred.
Overall perioperative mortality was 14.3%. The mortal-
ity rate of TPE patients was 21.4%, and that of APE pa-
tients was 14.3%. No perioperative deaths occurred inTable 2 Surgical outcomesa
Overall APE
Number of patients 28 7
Mean operating time (min) 269 310
Blood transfusion required, n (%) 22 (78.6%) 5 (71.4%)
Mean blood transfusion (units) 2.2 3.1
Mean stay ICU (days) 3.2 2.1
Mean total hospital stay (days) 9.3 6.3
Surgical site infection, n (%) 7 (25%) 1 (14.3%)
Need for reoperation, n (%) 7 (25%) 2 (28.6%)
Perioperative mortality, n (%) 4 (14.3%) 1 (14.3%)
aAPE, Anterior pelvic exenteration; NTE, Nontotal exenteration; PPE, Posterior pelvic
TPE and NTE, and P < 0.05 was set as the level of significance.the PPE group. There was no statistically significant dif-
ference in mortality between the TPE and NTE groups.
The analysis of the early postoperative complications
(at 30 days) was carried out according to the Clavien-
Dindo Classification. Postoperative complications were
more frequent and more severe in the TPE group than
in the NTE group; 78.6% of TPE patients experienced
some type of complication compared to 35.7% in the
NTE group (P = 0.02). Table 3 and Figure 1 present the
distribution and severity of complications as measured
according to the Clavien-Dindo Classification. The over-
all surgical site infection rate was 25%; in the individual
groups, the rates were 14.3% in the APE group, 0% in
the PPE group and 42.8% in the TPE group (P = 0.03).
Need for reoperation
One-fourth of patients required some form of surgical
reoperation. However, reoperations were more common
in patients who underwent TPE (35.7%) than in the APE
patients (28.6%). PPE patients required no further inter-
vention. There was no statistical difference in the rate of
reoperations. The most common reason for reoperation
was urinary fistula (57.1%) that was not manageable with
clinical or percutaneous treatment. The remaining cases
occurred because of evisceration along with internal her-
nia (one case) and small- bowel obstruction (two cases).
Urinary tract reconstruction and complications
The most common type of urinary reconstruction was wet
colostomy (ten cases), followed by ureterostomy (four
cases) and ileal conduit (three cases). The overall leakage
rate was 22.7%. Leakages were managed successfully with
conservative treatment in 40% of the cases. The remaining
patients required reoperation. The types of reconstruction
and complications are detailed in Table 4.
Colon reconstruction and complications
Excluding the 10 cases of wet colostomy, the other 11
patients required some form of colon reconstruction.PPE TPE NTE P-value
7 14 14 –
232 367 271 0.023
4 (57.1%) 13 (92.8%) 9 (64.3%) 0.082
0.8 2.6 1.9 0.456
2.1 4.3 2.1 0.138
8.7 11.1 7.5 0.129
0 6 (42.8%) 1 (7.1%) 0.038
0 5 (35.7%) 2 (14.2%) 0.192
0 3 (21.4%) 1 (7.1%) 0.297
exenteration; TPE, Total pelvic exenteration. P-value is for comparison between
Table 3 Surgical complications grade (Clavien-Dindo Classification)a
Overall APE PPE TPE NTE P-value
Number of patients 16/28 (57.1%) 3/7 (42.8%) 2/7 (28.6%) 11/14 (78.6%) 5/14 (35.7%) 0.024
I 0 0 0 0 0 –
II 6 (21.4%) 1 (14.3%) 1 (14.3%) 4 (28.6%) 2 (14.3%) 0.324
III 6 (21.4%) 1 (14.3%) 1 (14.3%) 4 (28.6%) 2 (14.3%) 0.324
IV 0 0 0 0 0 –
V 4 (14.3%) 1 (14.3%) 0 3 (21.4%) 1 (7.1%) 0.297
aAPE, Anterior pelvic exenteration; NTE, Nontotal exenteration; PPE, Posterior pelvic exenteration; TPE, Total pelvic exenteration. P-value is for comparison between
TPE and NTE, and P < 0.05 was set as the level of significance.
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and primary anastomosis in four; only one patient re-
ceived a protective stoma, a colostomy. As a routine, we
perform radiological control of the anastomosis only in
cases of a clinically apparent fistula. In the four patients
with colonic anastomosis, no clinically evident leakage
or related complications occurred.Neovagina
In the only attempt of genital reconstruction with neova-
gina, which was performed in a 45-year-old patient with
central recurrence of an irradiated stage IIB cervical
squamous cell carcinoma requiring TPE, partial necrosis
of the flap (gracilis muscle) occurred, resulting in sepsis
and a need for surgical debridement.Margin status after operation
A complete tumor resection with negative margins was
achieved in 92.8% of the operations, microscopically in-
volved margins in 4.3% (one case) and macroscopic re-
sidual disease in 4.3% (one case). In the latter case, at
the end of the operation, a small but nonresectable node
at the root of the mesentery was detected.Figure 1 Distribution of surgical complications. NTE, Nontotal exenteraAdjuvant therapy
Most of the patients (78.6%) did not receive any adju-
vant treatment.
Discussion
Our institution is a tertiary referral cancer center in the
south of Brazil, in which approximately 5,000 new pa-
tients with confirmed malignant neoplasia are treated
annually. On average, nearly 300 of them present with a
diagnosis of cervical carcinoma, and 84% of cases are
classified as stage II, III or IV [15].
Squamous cell carcinoma of the uterine cervix is the
most common gynecologic malignancy in developing
countries, including Brazil. In Brazil, most of the pa-
tients present upon diagnosis with locally advanced dis-
ease [16]. In our institution, the typical patient candidate
for possible PE is a woman with recurrent cervical car-
cinoma who has previously received primary treatment
with RT (pelvic RT plus brachytherapy). In our present
case review, this group comprised 57.1% of the cases.
Many of those cervical cancer patients already had lo-
cally advanced severe disease classified as clinical stage
IIIB at the time of the initial diagnosis (50% in our co-
hort). These population characteristics differ somehowtion; TPE, Total pelvic exenteration.
Table 4 Urinary tract reconstruction and fistulas




Wet colostomy 10 1 (10%)
Ileal conduit 3 1 (33.3%)
Segmental resection of the ureter 1 1 (100%)
Ureteral reimplant 2 2 (100%)
Nephrostomy 2 0
Ureterostomy 4 0
Overall 22 5 (22.7%)
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leading us to suppose that we are dealing with patients
in worse clinical condition.
PE remains the only curative procedure for patients
with recurrent cervical cancer after nonsurgical treatment
(RT with or without CT). Another condition where PE is
appropriate is primary ovarian cancer in which resection
of the bladder and/or rectum is necessary to achieve free
margins or optimal cytoreduction [6]. Also, uterine cancer
sometimes presents as a locally recurrent neoplasia in
which some irradiation of the pelvis has already been per-
formed as part of the primary treatment and for which a
radical surgical approach is necessary to pursue a curative
treatment [7]. Our sample also included one case of uter-
ine sarcoma.
The main purpose of this retrospective review was to
analyze surgical complications by comparing different
types of PE. We do not report survival analysis, given
the lack of follow-up time to date. TPE was the most
commonly performed operation, possibly because of re-
currence severity due to more advanced disease at
diagnosis.
The Clavien-Dindo Classification of surgical complica-
tion was used. On the basis of that system, the results
suggest not only that surgical complications are high in
incidence but also that they are severe in most cases.
After analyzing the profile of postoperative outcomes,
it seems that TPE is a procedure very distinct from APE
and PPE in terms of surgical complexity, operative time,
recovery time and, particularly, the rate and severity of
surgery-related complications. In our study, TPE led to a
statistically significant higher incidence of complications.
We could not demonstrate that those complications
were more severe than the complications that occurred
in the NTE group, possibly because of the small sample
size. However, there was a clear trend for worse compli-
cations in the TPE group in every single grade according
to Clavien-Dindo Classification.
Urinary diversion and reconstruction remains a ser-
ious issue in patients who undergo PE [17]. Most of
them had previously received pelvic irradiation with the
risk of chronic vascular alteration of the small bowel andurinary tract, mainly fibrosis and sclerosis of the small
vessels. Any kind of anastomosis using this poorly vascu-
larized tissue presents a high risk of leakage. We found
significant rates of complications after urinary recon-
struction, higher than is the rates reported by many
North American and European centers.
It is common in our public hospital setting that pa-
tients still receive two-dimensional irradiation, with low
utilization of techniques such as three-dimensional ir-
radiation, intensity-modulated RT and image-guided RT.
It has been demonstrated that those techniques can help
in lowering the radiation dose received by the small bowel,
particularly in the setting of extended-field RT [18,19]. In
our experience, the ileum quality and vascularization were
frequently impaired, as was the distal portion of ureters.
After an initial bad experience with ileal conduits, we
found wet colostomy to be a safer option and an attractive
alternative for patients treated with TPE.
On the basis of our results, we can explain some of
the apparent differences between the APE and PPE
groups. When PPE is performed, the urinary tract is
rarely manipulated, leading to a reduced chance of post-
operative complication. We did not make a direct com-
parison between those patients in our study, owing to
the limited size of both groups.
We report similar postoperative morbidity but a
higher mortality rate (14.3%) compared to other pub-
lished series of PE patients. Although an exact and
unique explanation for these results is difficult to find in
our small number of cases, some hypotheses and sugges-
tions for improvement can be offered.
Treatment protocols were not standardized during our
early years of experience, and, for that reason, several
modifications were implemented over time. The use of
wet colostomy as a urinary and fecal reconstruction
method after TPE seems to be a safer option, with some
authors suggesting that it is the best option in this sce-
nario [20-22]. A more systematic use of this reconstruc-
tion technique could lead to a reduction in urinary
diversion complications and operative mortality.
With widespread use of more modern RT techniques,
such as three-dimensional irradiation, in our public sys-
tem, we may expect fewer bowel-related complications
and deal with a better-vascularized ileum and terminal
ureter. Centralizing surgical expertise can also be an ef-
fective strategy to improve experience in uncommon
procedures such as PE.
An inferior overall clinical condition and lower socio-
economic status of the patients [23] may also have
played a role in our results.
Limitations
Major biases of our study are the retrospective nature of
the analysis and the limited number of patients. These
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the literature on PE. To date, only one study group has
prospectively analyzed surgical and survival outcomes of
this procedure [10]. Possible reasons for this are the rar-
ity of this operation in North America and Europe and
that there are only limited reports on this procedure
from countries that actually perform it in a more con-
stant and routine fashion, such as Brazil and countries
in Africa and Asia.
Conclusion
PE for the treatment of gynecologic malignancy is an ag-
gressive choice. The initial experience in our institution
shows high rates of morbidity and mortality, although
these rates are comparable to those of other series de-
scribed in the literature. Thus, patient selection must be
accurate, and it is advisable to perform this procedure
only in high-volume cancer centers with experience in
complex pelvic and abdominal surgery.
Major complications remain secondary to urinary re-
construction and infection. These are frequently severe
and usually require reoperation.
Patients requiring TPE seem to be part of a high-risk
subgroup with more challenging operations and worse
postoperative outcomes.
It is worth emphasizing that PE, although it is a high-
risk procedure, is the only curative option for these pa-
tients. In countries such as Brazil, the development of
experience in this field is fundamental because of the en-
demic behavior of this neoplasia, particularly in ad-
vanced stages.
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